BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 18254487)

  • 1. Safety of parecoxib in patients with nonsteroidal anti-inflammatory drug-induced urticaria or angioedema.
    Colanardi MC; Nettis E; Traetta P; Daprile C; Fitto C; Aloia AM; Di Leo E; Ferrannini A; Vacca A
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):82-5. PubMed ID: 18254487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib.
    Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):34-8. PubMed ID: 15702813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders.
    Asero R
    Ann Allergy Asthma Immunol; 1999 Jun; 82(6):554-8. PubMed ID: 10400483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs)].
    Boehncke S; Boehncke WH
    Dtsch Med Wochenschr; 2005 Oct; 130(40):2249-52. PubMed ID: 16208597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of nimesulide in patients with acetylsalicylic acid and nonsteroidal anti-inflammatory drug intolerance.
    Bavbek S; Celik G; Ediger D; Mungan D; Demirel YS; Misirligil Z
    J Asthma; 1999 Dec; 36(8):657-63. PubMed ID: 10609620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and nimesulide associated or not with common non-steroidal anti-inflammatory drugs.
    Liccardi G; Salzillo A; Piccolo A; Senna G; Piscitelli E; D'Amato M; D'Amato G
    Eur Ann Allergy Clin Immunol; 2005 Feb; 37(2):50-3. PubMed ID: 15859361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term and long-term tolerability of rofecoxib in patients with prior reactions to nonsteroidal anti-inflammatory drugs.
    Nettis E; Colanardi MC; Ferrannini A; Tursi A
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):29-33. PubMed ID: 15702812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal antiinflammatory drugs among young, Asian, atopic children.
    Kidon MI; Kang LW; Chin CW; Hoon LS; See Y; Goh A; Lin JT; Chay OM
    Pediatrics; 2005 Nov; 116(5):e675-80. PubMed ID: 16230465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaphylactoid reactions due to nonsteroidal antiinflammatory drugs: clinical and cross-reactivity studies.
    Quiralte J; Blanco C; Castillo R; Ortega N; Carrillo T
    Ann Allergy Asthma Immunol; 1997 Mar; 78(3):293-6. PubMed ID: 9087155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoreactivity is highly prevalent in patients with multiple intolerances to NSAIDs.
    Asero R; Tedeschi A; Lorini M
    Ann Allergy Asthma Immunol; 2002 May; 88(5):468-72. PubMed ID: 12027067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of ketoprofen oral challenges to detect cross-reactors among patients with a history of aspirin-induced urticaria.
    Asero R
    Ann Allergy Asthma Immunol; 2006 Aug; 97(2):187-9. PubMed ID: 16937749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NSAID-induced urticaria/angioedema does not evolve into chronic urticaria: a 12-year follow-up study.
    Doña I; Blanca-López N; Torres MJ; Gómez F; Fernández J; Zambonino MA; Monteseirín FJ; Canto G; Blanca M; Cornejo-García JA
    Allergy; 2014 Apr; 69(4):438-44. PubMed ID: 24372026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urticaria--angioedema induced by non-steroidal anti-inflammatory analgesics].
    Díez Gómez ML; Alvarez Cuesta E; Hinojosa Macías M; García Cañadillas F; Alcover Sánchez R
    Allergol Immunopathol (Madr); 1984; 12(3):179-88. PubMed ID: 6332509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactivity of cyclooxygenase 2 inhibitors in patients with a history of cutaneous reactions to cyclooxygenase 1 inhibitors.
    Simon RA; Stevenson DD
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):8-11. PubMed ID: 15702807
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of nonsteroidal inflammatory drug-induced urticaria and/or angioedema.
    Nosbaum A; Braire-Bourrel M; Dubost R; Faudel A; Parat S; Nicolas JF; Bérard F
    Ann Allergy Asthma Immunol; 2013 Apr; 110(4):263-6. PubMed ID: 23535090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The selective cyclooxygenase-2 inhibitor celecoxib is a safe alternative in patients with pseudo-allergic reactions to nonsteroidal anti-inflammatory drugs].
    Ahlbach S; Usadel KH; Kaufmann R; Boehncke WH
    Med Klin (Munich); 2003 Apr; 98(5):242-4. PubMed ID: 12721666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenge-based clinical patterns of 223 Spanish patients with nonsteroidal anti-inflammatory-drug-induced-reactions.
    Quiralte J; Blanco C; Delgado J; Ortega N; Alcntára M; Castillo R; Anguita JL; Sáenz de San Pedro B; Carrillo T
    J Investig Allergol Clin Immunol; 2007; 17(3):182-8. PubMed ID: 17583106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of the clinical history in the diagnosis of urticaria/angioedema induced by NSAIDs with cross-intolerance.
    Blanca-Lopez N; J Torres M; Doña I; Campo P; Rondón C; Seoane Reula ME; Salas M; Canto G; Blanca M
    Clin Exp Allergy; 2013 Jan; 43(1):85-91. PubMed ID: 23278883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Floctafenine: a valid alternative in patients with adverse reactions to nonsteroidal anti-inflammatory drugs.
    Giuseppe P; Antonino R; Alessandro DB; Donato Q; Marina DF; Donatella P; Francesca G; Alberto V
    Ann Allergy Asthma Immunol; 1997 Jan; 78(1):74-8. PubMed ID: 9012626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Safety of reintroducing platelet-inhibitory doses of aspirin in patients with urticaria or angioedema induced by anti-inflammatory doses].
    Vial A; Mathelier-Fusade P; Gaouar H; Leynadier F; Chosidow O; Aractingi S; Francès C
    Ann Dermatol Venereol; 2009 Jan; 136(1):15-20. PubMed ID: 19171224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.